Avantor
General Information | |
Business: |
We are a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our comprehensive offerings, which include materials & consumables, equipment & instrumentation and services & specialty procurement, are relied upon by our customers, often on a recurring basis, because they are frequently specified into their research, development and production processes. These processes are commonly organized into “workflows” that define the activities our customers perform each day. |
Industry: | LABORATORY ANALYTICAL INSTRUMENTS |
Employees: | 12000 |
Founded: | 1904 |
Contact Information | |
Address | Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087, US |
Phone Number | (610) 386-1700 |
Web Address | http://www.avantorinc.com |
View Prospectus: | Avantor |
Financial Information | |
Market Cap | $7480.1mil |
Revenues | $5926.1 mil (last 12 months) |
Net Income | $-51.9 mil (last 12 months) |
IPO Profile | |
Symbol | AVTR |
Exchange | NYSE |
Shares (millions): | 207.0 |
Price range | $14.00 - $14.00 |
Est. $ Volume | $2898.0 mil |
Manager / Joint Managers | Goldman Sachs/ J.P. Morgan/ BofA Securities/ Barclays/ Jefferies |
CO-Managers | Credit Suisse/ Deutsche Bank Securities/ Evercore/ Guggenheim Securities/ Morgan Stanley/ UBS Investment Bank/ Citigroup/ Cowen and Company/ Piper Jaffray/ RBC Capital Markets/ Baird/ William Blair/ Janney Montgomery Scott/ KeyBanc Capital Markets/ PJT Partners/ Raymond James/ Stephens, Inc./ Stifel/ SunTrust Robinson Humphrey/ Wells Fargo Securities/ Drexel Hamilton |
Expected To Trade: | 5/17/2019 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |